Elsevier

Toxicon

Volume 54, Issue 5, October 2009, Pages 550-560
Toxicon

Receptor and substrate interactions of clostridial neurotoxins

https://doi.org/10.1016/j.toxicon.2008.12.027Get rights and content

Abstract

The high potency of clostridial neurotoxins relies predominantly on their neurospecific binding and specific hydrolysis of SNARE proteins. Their multi-step mode of mechanism can be ascribed to their multi-domain three-dimensional structure. The C-terminal HCC-domain interacts subsequently with complex polysialo-gangliosides such as GT1b and a synaptic vesicle protein receptor via two neighbouring binding sites, resulting in highly specific uptake of the neurotoxins at synapses of cholinergic motoneurons. After its translocation the enzymatically active light chain specifically hydrolyses specific SNARE proteins, preventing SNARE complex assembly and thereby blocking exocytosis of neurotransmitter.

Introduction

The family of clostridial neurotoxins (CNTs) consists of tetanus neurotoxin (TeNT) and the seven botulinum neurotoxin serotypes (BoNT/A-G), and represents the most toxic agents known. The median lethal dose is below 1 ng per kg of body weight (Gill, 1982). The disease tetanus is caused by germination of Gram-positive, anaerobic spore-forming Clostridium tetani in infected tissue lesions, thereby producing and releasing TeNT into the blood stream. In contrast, botulism is evoked by ingestion of acid resistant BoNT progenitor toxins, generated by various strains of C. botulinum, C. butyricum and C. barati, and subsequent transcytosis of this complex or the released BoNT through the intestinal epithelial barrier (Bigalke and Shoer, 2000). The CNTs reach the motoneurons via circulation and specifically bind to unmyelinated areas of nerve terminals (Dolly et al., 1984). Here, BoNTs inhibit acetylcholine release followed by flaccid paralysis while TeNT is transported retrogradely to inhibitory neurons and blocks release of glycine or γ-aminobutyric acid which results in spastic paralysis.

The crystal structures of the BoNT/A, B and E holotoxins (Lacy et al., 1998, Swaminathan and Eswaramoorthy, 2000, Kumaran et al., 2009) revealed that most likely all CNTs are composed of four functionally independent domains that perform individual tasks in the multi-step intoxication process (Fig. 1). All CNTs are produced as ∼150 kDa single chain (sc) proteins. They are post-translationally proteolysed into a ∼100 kDa heavy chain (HC) and a ∼50 kDa light chain (LC). Both chains remain associated by a single disulphide bridge, non-covalent interactions and an HC derived peptide loop wrapping around the LC. The HCs are responsible for neurospecific binding, uptake and translocation of the LCs into the cytosol. Following cell attachment, internalisation via receptor-mediated endocytosis brings the BoNTs into the synaptic vesicles. Here, the acidic environment eliminates repulsive electrostatic interactions between the largely α-helical amino-terminal half of the HC, the HN-domain and the membrane, allowing its penetration into the membrane, without triggering detectable structural changes (Galloux et al., 2008). At the same time the LC is partially unfolded (Koriazova and Montal, 2003). Translocation of LC by HC can be observed in real time as an increase of channel conductance. The HC channel is occluded by the LC during transit, then unoccluded after completion of translocation and release of LC (Fischer and Montal, 2007b). Upon reduction of the disulphide bond, the LC functions as a zinc dependent endopeptidase in the cytosol (Fischer and Montal, 2007a, Schiavo et al., 1990).

Section snippets

Gangliosides as receptors for CNTs

The specific binding to peripheral nerve endings at the neuromuscular junction solely involves the 50 kDa C-terminal half of the HC, the HC-fragment (Evinger and Erichsen, 1986, Fishman and Carrigan, 1987, Lalli et al., 1999, Simpson, 1984a, Simpson, 1984b, Simpson, 1985) and complex polysialo-gangliosides, glycosphingolipids that are found particularly in membranes of neuronal cells (Simpson and Rapport, 1971, van Heyningen and Miller, 1961). The interaction of gangliosides with CNTs was

A protein is the second receptor for CNTs

The discrepancy in affinity between binding of CNTs to isolated gangliosides and neuronal tissue prompted predictions of a second receptor component. The protease-sensitive binding of BoNT/A and TeNT to rat brain synaptosomes (Dolly et al., 1982, Kitamura, 1976, Lazarovici and Yavin, 1986, Pierce et al., 1986) resulted in a dual receptor model. First, polysialo-gangliosides were considered to accumulate CNTs on the plasma membrane surface. Then, CNTs would simply stay on the surface until

Characterisation of binding sites in CNTs

The crystal structure of the TeNT HC-fragment revealed that it is composed of two domains, an N-terminal lectin-like jelly-roll domain (HCN, residues 865–1110) and a C-terminal β-trefoil domain (HCC, residues 1110–1315) (Knapp et al., 1998, Umland et al., 1997). Deletion mutagenesis studies showed that the TeNT HCC-domain binds to gangliosides and neuronal cells even more efficiently than the complete HC-fragment (Halpern and Loftus, 1993), whereas the HCN-domain does not bind at all (

CNT LC proteases

BoNT and TeNT LCs are amongst the most selective proteases known (Oost et al., 2003). Primary sequence and structural analysis of LCs suggest that their enzymatic mechanism is related to that of other Zn2+-metalloproteases (Agarwal et al., 2004, Breidenbach and Brunger, 2005, Lacy et al., 1998, Rao et al., 2005, Swaminathan and Eswaramoorthy, 2000), but the structural basis of SNARE target selectivity is unusual. Remarkably, the LCs do not appear to recognise a consensus site, or even have

LC–substrate interactions

The structure of a BoNT/A·LC–SNAP-25 complex (PDB ID 1XTG) (Breidenbach and Brunger, 2004) for the first time provided molecular insights into the basis of LC substrate selectivity (Fig. 4). To date, this is the only structure of a complex between a CNT-LC and its substrate. A previous report of the structure of a complex between BoNT/B-LC and synaptobrevin 2 (Hanson and Stevens, 2000) is not supported by the experimental data (Breidenbach and Brunger, 2004, Rupp and Segelke, 2001) and the

LC–inhibitor interactions and implications for drug development

For many years, complexes between LC proteases and inhibitors resisted attempts at co-crystallisation. Over the past two years, dramatic progress has been made resulting in co-crystal structures of several inhibitor-BoNT/A LC complexes (Fu et al., 2006, Kumaran et al., 2008a, Kumaran et al., 2008b, Silvaggi et al., 2007, Silvaggi et al., 2008, Zuniga et al., 2008). Co-crystal structures with small hydroxamate compounds and tetrapeptides, all including an Arg moiety, have now uniquely identified

References (125)

  • A. Fischer et al.

    Crucial role of the disulfide bridge between botulinum neurotoxin light and heavy chains in protease translocation across membranes

    J. Biol. Chem.

    (2007)
  • P.S. Fishman et al.

    Retrograde transneuronal transfer of the C-fragment of tetanus toxin

    Brain Res.

    (1987)
  • C. Fotinou et al.

    The crystal structure of tetanus toxin HC-fragment complexed with a synthetic GT1b analogue suggests cross-linking between ganglioside receptors and the toxin

    J. Biol. Chem.

    (2001)
  • M. Galloux et al.

    Membrane interaction of botulinum neurotoxin A T domain: The belt region is a regulatory loop for membrane interaction

    J. Biol. Chem.

    (2008)
  • M. Geppert et al.

    Synaptotagmin II. A novel differentially distributed form of synaptotagmin

    J. Biol. Chem.

    (1991)
  • J.L. Halpern et al.

    Characterization of the receptor-binding domain of tetanus toxin

    J. Biol. Chem.

    (1993)
  • H. Ihara et al.

    Sequence of the gene for Clostridium botulinum type B neurotoxin associated with infant botulism, expression of the C-terminal half of heavy chain and its binding activity

    Biochim. Biophys. Acta

    (2003)
  • M. Kitamura et al.

    Gangliosides are the binding substances in neural cells for tetanus and botulinum toxins in mice

    Biochim. Biophys. Acta

    (1999)
  • M. Kitamura et al.

    Different response of the knockout mice lacking b-series gangliosides against botulinum and tetanus toxins

    Biochim. Biophys. Acta

    (2005)
  • S. Kozaki et al.

    Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins

    Microb. Pathog.

    (1998)
  • D. Kumaran et al.

    Structure- and substrate-based inhibitor design for Clostridium botulinum neurotoxin serotype A. J

    Biol. Chem.

    (2008)
  • D. Kumaran et al.

    Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation

    J. Mol. Biol.

    (2009)
  • S. Mahrhold et al.

    The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves

    FEBS Lett.

    (2006)
  • P. Marxen et al.

    Tetanus toxin: inhibitory action in chromaffin cells is initiated by specified types of gangliosides and promoted in low ionic strength solution

    Neurosci. Lett.

    (1989)
  • P. Marxen et al.

    Gangliosides mediate inhibitory effects of tetanus and botulinum A neurotoxins on exocytosis in chromaffin cells

    Toxicon

    (1989)
  • P. Marxen et al.

    The translocation of botulinum A neurotoxin by chromaffin cells is promoted in low ionic strength solution and is insensitive to trypsin

    Toxicon

    (1991)
  • C. Montecucco

    How do tetanus and botulinum neurotoxins bind to neuronal membranes?

    Trends Biochem. Sci.

    (1986)
  • P. Munro et al.

    High sensitivity of mouse neuronal cells to tetanus toxin requires a GPI-anchored protein

    Biochem. Biophys. Res. Commun.

    (2001)
  • T. Nishiki et al.

    Solubilization and characterization of the acceptor for Clostridium botulinum type B neurotoxin from rat brain synaptic membranes

    Biochim. Biophys. Acta

    (1993)
  • T. Nishiki et al.

    Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes

    J. Biol. Chem.

    (1994)
  • T. Nishiki et al.

    The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a

    FEBS Lett.

    (1996)
  • T. Nishiki et al.

    Binding of botulinum type B neurotoxin to Chinese hamster ovary cells transfected with rat synaptotagmin II cDNA

    Neurosci. Lett.

    (1996)
  • R. Pellizzari et al.

    Structural determinants of the specificity for synaptic vesicle-associated membrane protein/synaptobrevin of tetanus and botulinum type B and G neurotoxins

    J. Biol. Chem.

    (1996)
  • M.S. Perin et al.

    Domain structure of synaptotagmin (p65)

    J. Biol. Chem.

    (1991)
  • K.N. Rao et al.

    Structural analysis of the catalytic domain of tetanus neurotoxin

    Toxicon

    (2005)
  • A. Rummel et al.

    Two carbohydrate binding sites in the H(CC)-domain of tetanus neurotoxin are required for toxicity

    J. Mol. Biol.

    (2003)
  • A. Rummel et al.

    Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G. J

    Biol. Chem.

    (2004)
  • G. Schiavo et al.

    Botulinum neurotoxin type C cleaves a single Lys-Ala bond within the carboxyl-terminal region of syntaxins

    J. Biol. Chem.

    (1995)
  • J.J. Schmidt et al.

    Type A botulinum neurotoxin proteolytic activity: development of competitive inhibitors and implications for substrate specificity at the S1′ binding subsite

    FEBS Lett.

    (1998)
  • R.E. Shapiro et al.

    Identification of a ganglioside recognition domain of tetanus toxin using a novel ganglioside photoaffinity ligand

    J. Biol. Chem.

    (1997)
  • S. Sikorra et al.

    Identification of the amino acid residues rendering TI-VAMP insensitive toward botulinum neurotoxin

    B. J. Mol. Biol.

    (2006)
  • S. Sikorra et al.

    Substrate recognition mechanism of VAMP/Synaptobrevin-cleaving clostridial neurotoxins

    J. Biol. Chem.

    (2008)
  • R. Agarwal et al.

    Structural analysis of botulinum neurotoxin type E catalytic domain and its mutant Glu212→Gln reveals the pivotal role of the Glu212 carboxylate in the catalytic pathway

    Biochemistry

    (2004)
  • R. Agarwal et al.

    Structural analysis of botulinum neurotoxin serotype F light chain: implications on substrate binding and inhibitor design

    Biochemistry

    (2005)
  • J.W. Arndt et al.

    Crystal structure of botulinum neurotoxin type G light chain: serotype divergence in substrate recognition

    Biochemistry

    (2005)
  • J.W. Arndt et al.

    Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity

    Biochemistry

    (2006)
  • M.R. Baldwin et al.

    Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes

    Biochemistry

    (2007)
  • H. Bigalke et al.

    Clostridial neurotoxins

  • T. Binz et al.

    Arg(362) and Tyr(365) of the botulinum neurotoxin type a light chain are involved in transition state stabilization

    Biochemistry

    (2002)
  • J.D. Black et al.

    Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves

    J. Cell Biol.

    (1986)
  • Cited by (0)

    View full text